High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the prob...
Saved in:
| Published in | BMC infectious diseases Vol. 20; no. 1; p. 847 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
16.11.2020
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa.
This retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection.
A total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7-9.3] at baseline and 9.4% (95%CI: 8.6-10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14-3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06-6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77-7.35).
The provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. |
|---|---|
| AbstractList | Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa. This retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection. A total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7-9.3] at baseline and 9.4% (95%CI: 8.6-10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14-3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06-6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77-7.35). The provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. Abstract Background Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa. Methods This retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection. Results A total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7–9.3] at baseline and 9.4% (95%CI: 8.6–10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14–3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06–6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77–7.35). Conclusion The provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. Background Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa. Methods This retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection. Results A total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7–9.3] at baseline and 9.4% (95%CI: 8.6–10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14–3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06–6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77–7.35). Conclusion The provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. BACKGROUNDHepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa. METHODSThis retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection. RESULTSA total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7-9.3] at baseline and 9.4% (95%CI: 8.6-10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14-3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06-6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77-7.35). CONCLUSIONThe provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. Background Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa. Methods This retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection. Results A total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7-9.3] at baseline and 9.4% (95%CI: 8.6-10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14-3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06-6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77-7.35). Conclusion The provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. Keywords: HBV incidence, HIV/HBV coinfection, South Africa Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care provision for HIV-TB co-infected patients to better understand the relationship between these coinfections, determine the magnitude of the problem, and identify risk factors for HBV infection in HIV infected patients with and without TB in KwaZulu-Natal, South Africa. This retrospective cohort analysis was undertaken in 2018. In-care HIV infected patients were included in the analysis. Results from clinical records were analysed to determine the prevalence, incidence, persistence and factors associated with HBsAg positivity in HIV-infected patients with or without TB co-infection. A total of 4292 HIV-infected patients with a mean age of 34.7 years (SD: 8.8) were included. Based on HBsAg positivity, the prevalence of HBV was 8.5% (363/4292) [95% confidence interval (CI): 7.7-9.3] at baseline and 9.4% (95%CI: 8.6-10.3%) at end of follow-up. The HBV incidence rate was 2.1/100 person-years (p-y). Risk of incident HBV infection was two-fold higher among male patients (HR 2.11; 95% CI: 1.14-3.92), while severe immunosuppression was associated with a greater than two-fold higher risk of persistent infection (adjusted risk ratio (RR) 2.54; 95% CI 1.06-6.14; p = 0.004. Additionally, active TB at enrolment was associated with a two-fold higher risk of incident HBV infection (aHR 2.38; 95% CI: 0.77-7.35). The provision of HIV care and treatment in high HBV burden settings provide a missed opportunity for HBV screening, immunization and care provision. |
| ArticleNumber | 847 |
| Audience | Academic |
| Author | Govender, Kerusha Naidoo, Kogieleum Abdool-Karim, Salim Padayatchi, Nesri Mlisana, Koleka Msomi, Nokukhanya Abdool-Karim, Quarraisha Yende-Zuma, Nonhlanhla Singh, Jerome Amir |
| Author_xml | – sequence: 1 givenname: Nokukhanya orcidid: 0000-0002-0610-6100 surname: Msomi fullname: Msomi, Nokukhanya email: mdlalose@ukzn.ac.za organization: Discipline of Virology-University of KwaZulu-Natal, School of Laboratory Medicine and Medical Sciences and National Health Laboratory Service, Durban, South Africa. mdlalose@ukzn.ac.za – sequence: 2 givenname: Kogieleum surname: Naidoo fullname: Naidoo, Kogieleum organization: MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa – sequence: 3 givenname: Nonhlanhla surname: Yende-Zuma fullname: Yende-Zuma, Nonhlanhla organization: MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa – sequence: 4 givenname: Nesri surname: Padayatchi fullname: Padayatchi, Nesri organization: MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa – sequence: 5 givenname: Kerusha surname: Govender fullname: Govender, Kerusha organization: Discipline of Virology-University of KwaZulu-Natal, School of Laboratory Medicine and Medical Sciences and National Health Laboratory Service, Durban, South Africa – sequence: 6 givenname: Jerome Amir surname: Singh fullname: Singh, Jerome Amir organization: Dalla Lana School of Public Health, University of Toronto, Toronto, Canada – sequence: 7 givenname: Salim surname: Abdool-Karim fullname: Abdool-Karim, Salim organization: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA – sequence: 8 givenname: Quarraisha surname: Abdool-Karim fullname: Abdool-Karim, Quarraisha organization: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA – sequence: 9 givenname: Koleka surname: Mlisana fullname: Mlisana, Koleka organization: National Health Laboratory Service and School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33198649$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1v0zAYxiM0xD7gH-CAInEBiQx_xU4uSGUatGJiEoMduFiO_SZ1lcbFdsq48LfjtmOsiAOyJX_9nsfy6-c4OxjcAFn2FKNTjCv-OmBSibpABBWoLEVZ8AfZEWYCF4RSdnBvfpgdh7BACIuK1I-yQ0pxXXFWH2U_p7ab53bQ1sCgIVeDyVfggw1xu3ZtPoeVijbakL_N19aPIeEt6GjdkGapG7u2ZlR9yD1oSIuhy6ez61wrDxviw3f1dezH4qOKqn-VX7kxzvNJ661Wj7OHbRLCk9vxJPvy7vzz2bS4uHw_O5tcFJpTHAulSjCYEiActY3QhvESiCkFg1pApWqiBcIMsKE8PYtBRStADSlZbdqm1PQkm-18jVMLufJ2qfwP6ZSV2w3nO6l8tLoHqUQJCnGtMS6ZANwY1hLcaNLWHAsCyevNzms1NkswGoboVb9nun8y2Lns3FoKLhDHKBm8uDXw7tsIIcqlDRr6Xg3gxiAJ45jWFAmR0Od_oQs3-iGVakvVtGKk-kN1Kj0g_Y5L9-qNqZxwRlJKULnxOv0HlZqBpdUpWq1N-3uCl3uCxES4iZ0aQ5Czq0__z15e77Nkx2rvQvDQ3tUOI7lJttwlW6Zky22yJU-iZ_erfif5HWX6CyVV81A |
| CitedBy_id | crossref_primary_10_12688_f1000research_132498_2 crossref_primary_10_1016_j_ijid_2024_02_001 crossref_primary_10_12688_f1000research_132498_1 crossref_primary_10_3390_microorganisms12061207 crossref_primary_10_1186_s12879_022_07697_5 crossref_primary_10_3390_jcm11226620 crossref_primary_10_1093_cid_ciab1020 crossref_primary_10_3389_fviro_2023_1160078 crossref_primary_10_3390_v14040788 crossref_primary_10_3390_venereology2010001 crossref_primary_10_4236_ojmm_2024_141001 crossref_primary_10_1016_j_coi_2021_03_010 crossref_primary_10_3389_fmicb_2024_1342862 crossref_primary_10_3390_v14091939 crossref_primary_10_1186_s12889_023_15130_y crossref_primary_10_4102_sajhivmed_v25i1_1543 |
| Cites_doi | 10.1016/j.chom.2009.10.010 10.1016/S0140-6736(17)30403-8 10.2105/AJPH.91.6.965 10.1097/QAD.0000000000001399 10.1093/infdis/jir720 10.1097/QAI.0b013e31811eadbc 10.1016/j.vaccine.2008.10.004 10.1111/jvh.12255 10.1056/NEJMoa0905848 10.1016/S0140-6736(02)11913-1 10.1111/liv.13640 10.1097/01.aids.0000163936.99401.fe 10.1002/hep.26635 10.1093/infdis/158.3.666 10.7326/0003-4819-157-5-201209040-00004 10.1093/epirev/mxj009 10.1016/j.vaccine.2019.03.029 10.1056/NEJMoa1014181 10.1371/journal.pone.0184124 10.1001/jamainternmed.2014.4010 10.5812/hepatmon.7876 10.1016/S0140-6736(15)61412-X 10.1073/pnas.74.6.2561 10.1086/420744 10.3748/wjg.v20.i46.17360 10.1016/j.jhep.2005.11.015 10.1016/S1386-6532(05)00384-7 10.1136/gut.2005.065136 10.1016/S1665-2681(19)31872-1 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
| Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12879-020-05575-6 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Science in Context ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2334 |
| EndPage | 847 |
| ExternalDocumentID | oai_doaj_org_article_a75ea06cc11547e1bd4f21bc2f96172e A642287057 10_1186_s12879_020_05575_6 33198649 |
| Genre | Journal Article |
| GeographicLocations | South Africa Africa |
| GeographicLocations_xml | – name: South Africa – name: Africa |
| GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION AFGXO 7QL 7T2 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c631t-aa5ed132e260fb7cd465e2d574e97e8a92c7014e1d366494e838e0b2549dfb5c3 |
| IEDL.DBID | RPM |
| ISSN | 1471-2334 |
| IngestDate | Tue Oct 22 15:09:07 EDT 2024 Tue Sep 17 21:21:26 EDT 2024 Fri Oct 25 01:51:56 EDT 2024 Thu Oct 10 19:47:05 EDT 2024 Tue Nov 19 21:06:18 EST 2024 Tue Nov 12 22:44:17 EST 2024 Thu Aug 01 19:19:33 EDT 2024 Thu Aug 01 20:28:26 EDT 2024 Thu Nov 21 23:31:36 EST 2024 Sat Sep 28 08:27:15 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | HBV incidence South Africa HIV/HBV coinfection |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c631t-aa5ed132e260fb7cd465e2d574e97e8a92c7014e1d366494e838e0b2549dfb5c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-0610-6100 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670610/ |
| PMID | 33198649 |
| PQID | 2461938428 |
| PQPubID | 42582 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a75ea06cc11547e1bd4f21bc2f96172e pubmedcentral_primary_oai_pubmedcentral_nih_gov_7670610 proquest_miscellaneous_2461393077 proquest_journals_2461938428 gale_infotracmisc_A642287057 gale_infotracacademiconefile_A642287057 gale_incontextgauss_ISR_A642287057 gale_incontextgauss_IOV_A642287057 crossref_primary_10_1186_s12879_020_05575_6 pubmed_primary_33198649 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-11-16 |
| PublicationDateYYYYMMDD | 2020-11-16 |
| PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC infectious diseases |
| PublicationTitleAlternate | BMC Infect Dis |
| PublicationYear | 2020 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | Organization WH (5575_CR34) 2016 OE Simani (5575_CR26) 2009; 27 JA Otegbayo (5575_CR29) 2008; 7 CL Thio (5575_CR31) 2002; 360 HM Chun (5575_CR10) 2011; 205 X Ma (5575_CR21) 2007; 45 S Sherlock (5575_CR7) 1987; 63 5575_CR9 CW Shepard (5575_CR6) 2006; 28 Y Lazizi (5575_CR25) 1988; 158 5575_CR1 D Konopnicki (5575_CR11) 2005; 19 5575_CR28 5575_CR27 A Schweitzer (5575_CR2) 2015; 386 B-C Phung (5575_CR3) 2014; 20 K Ito (5575_CR12) 2014; 59 D Lavanchy (5575_CR20) 2005; 34 K Naidoo (5575_CR19) 2012; 157 SS Abdool Karim (5575_CR18) 2010; 362 W-H Sheng (5575_CR32) 2004; 38 JF Okulicz (5575_CR24) 2015; 175 WT London (5575_CR30) 1977; 74 M Puoti (5575_CR8) 2006; 44 A Kramvis (5575_CR13) 2018; 108 E Seremba (5575_CR23) 2017; 31 E Loggi (5575_CR33) 2014; 21 M Subic (5575_CR14) 2018; 38 K Naidoo (5575_CR15) 2017; 12 SS Abdool Karim (5575_CR16) 2011; 365 DA MacKellar (5575_CR22) 2001; 91 AC Tsai (5575_CR4) 2017; 389 5575_CR17 A Lisco (5575_CR5) 2009; 6 |
| References_xml | – volume: 6 start-page: 403 issue: 5 year: 2009 ident: 5575_CR5 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2009.10.010 contributor: fullname: A Lisco – volume: 389 start-page: 978 issue: 10072 year: 2017 ident: 5575_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(17)30403-8 contributor: fullname: AC Tsai – volume: 91 start-page: 965 issue: 6 year: 2001 ident: 5575_CR22 publication-title: Am J Public Health doi: 10.2105/AJPH.91.6.965 contributor: fullname: DA MacKellar – volume: 31 start-page: 781 issue: 6 year: 2017 ident: 5575_CR23 publication-title: Aids doi: 10.1097/QAD.0000000000001399 contributor: fullname: E Seremba – volume: 205 start-page: 185 issue: 2 year: 2011 ident: 5575_CR10 publication-title: J Infect Dis doi: 10.1093/infdis/jir720 contributor: fullname: HM Chun – volume: 45 start-page: 581 issue: 5 year: 2007 ident: 5575_CR21 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31811eadbc contributor: fullname: X Ma – volume: 27 start-page: 146 issue: 1 year: 2009 ident: 5575_CR26 publication-title: Vaccine. doi: 10.1016/j.vaccine.2008.10.004 contributor: fullname: OE Simani – volume: 21 start-page: 305 issue: 5 year: 2014 ident: 5575_CR33 publication-title: J Viral Hepat doi: 10.1111/jvh.12255 contributor: fullname: E Loggi – volume: 362 start-page: 697 issue: 8 year: 2010 ident: 5575_CR18 publication-title: N Engl J Med doi: 10.1056/NEJMoa0905848 contributor: fullname: SS Abdool Karim – volume: 360 start-page: 1921 issue: 9349 year: 2002 ident: 5575_CR31 publication-title: Lancet doi: 10.1016/S0140-6736(02)11913-1 contributor: fullname: CL Thio – volume: 38 start-page: 115 issue: S1 year: 2018 ident: 5575_CR14 publication-title: Liver Int doi: 10.1111/liv.13640 contributor: fullname: M Subic – volume: 19 start-page: 593 issue: 6 year: 2005 ident: 5575_CR11 publication-title: Aids doi: 10.1097/01.aids.0000163936.99401.fe contributor: fullname: D Konopnicki – volume: 59 start-page: 89 issue: 1 year: 2014 ident: 5575_CR12 publication-title: Hepatology. doi: 10.1002/hep.26635 contributor: fullname: K Ito – ident: 5575_CR17 – volume: 158 start-page: 666 issue: 3 year: 1988 ident: 5575_CR25 publication-title: J Infect Dis doi: 10.1093/infdis/158.3.666 contributor: fullname: Y Lazizi – volume: 157 start-page: 313 issue: 5 year: 2012 ident: 5575_CR19 publication-title: Ann Intern Med doi: 10.7326/0003-4819-157-5-201209040-00004 contributor: fullname: K Naidoo – volume: 28 start-page: 112 issue: 1 year: 2006 ident: 5575_CR6 publication-title: Epidemiol Rev doi: 10.1093/epirev/mxj009 contributor: fullname: CW Shepard – ident: 5575_CR27 doi: 10.1016/j.vaccine.2019.03.029 – volume-title: Combating hepatitis B and C to reach elimination by 2030: advocacy brief year: 2016 ident: 5575_CR34 contributor: fullname: Organization WH – ident: 5575_CR1 – volume: 365 start-page: 1492 issue: 16 year: 2011 ident: 5575_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMoa1014181 contributor: fullname: SS Abdool Karim – volume: 12 start-page: e0184124 issue: 9 year: 2017 ident: 5575_CR15 publication-title: PloS one doi: 10.1371/journal.pone.0184124 contributor: fullname: K Naidoo – volume: 175 start-page: 88 issue: 1 year: 2015 ident: 5575_CR24 publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2014.4010 contributor: fullname: JF Okulicz – ident: 5575_CR9 doi: 10.5812/hepatmon.7876 – volume: 386 start-page: 1546 issue: 10003 year: 2015 ident: 5575_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(15)61412-X contributor: fullname: A Schweitzer – volume: 74 start-page: 2561 issue: 6 year: 1977 ident: 5575_CR30 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.74.6.2561 contributor: fullname: WT London – volume: 38 start-page: 1471 issue: 10 year: 2004 ident: 5575_CR32 publication-title: Clin Infect Dis doi: 10.1086/420744 contributor: fullname: W-H Sheng – volume: 20 start-page: 17360 issue: 46 year: 2014 ident: 5575_CR3 publication-title: World J Gastroenterol: WJG doi: 10.3748/wjg.v20.i46.17360 contributor: fullname: B-C Phung – volume: 63 start-page: 7 issue: Suppl 2 year: 1987 ident: 5575_CR7 publication-title: Postgrad Med J contributor: fullname: S Sherlock – volume: 108 start-page: 17 issue: 8b year: 2018 ident: 5575_CR13 publication-title: Suid-Afrikaanse tydskrif vir geneeskunde contributor: fullname: A Kramvis – volume: 44 start-page: S65 year: 2006 ident: 5575_CR8 publication-title: J Hepatol doi: 10.1016/j.jhep.2005.11.015 contributor: fullname: M Puoti – volume: 34 start-page: S1 year: 2005 ident: 5575_CR20 publication-title: J Clin Virol doi: 10.1016/S1386-6532(05)00384-7 contributor: fullname: D Lavanchy – ident: 5575_CR28 doi: 10.1136/gut.2005.065136 – volume: 7 start-page: 152 issue: 2 year: 2008 ident: 5575_CR29 publication-title: Ann Hepatol doi: 10.1016/S1665-2681(19)31872-1 contributor: fullname: JA Otegbayo |
| SSID | ssj0017829 |
| Score | 2.4084923 |
| Snippet | Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity of care... Background Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity... BACKGROUNDHepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the opportunity... Abstract Background Hepatitis B virus (HBV), Human Immunodeficiency virus (HIV) and Tuberculosis (TB) are common infections in South Africa. We utilized the... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 847 |
| SubjectTerms | Acquired immune deficiency syndrome Adult AIDS AIDS-Related Opportunistic Infections - diagnosis AIDS-Related Opportunistic Infections - drug therapy AIDS-Related Opportunistic Infections - epidemiology AIDS-Related Opportunistic Infections - virology Analysis Anti-HIV Agents - therapeutic use Care and treatment Coinfection - epidemiology Coinfection - virology Comorbidity Complications and side effects Confidence intervals Diagnosis Female Follow-Up Studies HBV incidence Health risks Hepatitis Hepatitis B Hepatitis B - diagnosis Hepatitis B - epidemiology Hepatitis B - virology Hepatitis B surface antigen Hepatitis B Surface Antigens - immunology Hepatitis B virus - immunology HIV HIV infections HIV/HBV coinfection Human immunodeficiency virus Humans Immunization Immunosuppression Incidence Infections Infectious diseases Laboratories Male Mycobacterium tuberculosis - isolation & purification Patients Prevalence Retrospective Studies Risk analysis Risk Factors South Africa South Africa - epidemiology Tuberculosis Tuberculosis - diagnosis Tuberculosis - epidemiology Tuberculosis - microbiology Viruses Young Adult |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kB_Eivl2N0orgQZvMox_Tx0QMGyUR1ITgpelnMiCzIbOjN3-7VfNYdhDx4m3Zrl12q6qr-qup_oqQV4IDjvClZ6UUnHGbJeYKERiOD6mStuBWWNA_PpHLU_7hXJxvjfrCnrCBHnhQ3J5VItpMeo-8MSrmLvBU5M4XSWPyjX30zYoJTI3PDyDv6emKTCX3WojCSjOESsg5JZicpaGerf_PmLyVlOYNk1sZ6PAOuT0eHen-8JPvkhuxuUduHo8Px--TX9izQbF23s8JpbYJ9ArLYW1_LqarRC8jNlCv65Ye0B_1ddfSqRmrgVe03tzOailEwlhjtYEuj84oNoihxMef9lv3vWMnWPV5S_sBfHSYNfSAnB6-__puycbxCszLMl8za0UMAEYjQJrklA9cilgEoXjUKlZWF14BgIp5KKXkmseqrGLmEFGG5IQvH5KdZtXEx4TK3BbW5Z4nQF-BByfBUL4SSbvCiiotyJtJ2-ZqYNEwPfqopBlsY8A2preNkQtygAbZSCIDdv8G-IUZ_cL8yy8W5CWa0yDHRYNNNBe2a1tz9OnM7EvkPVNwUv2b0JfPM6HXo1BagfW9HS8uwF9H7qyZ5O5MEnaqny9PrmXGSNEa5PPTZQUocEFebJbxk9j91sRVN8iUGrYNfMWjwRM3yikhhlZgngVRMx-daW--0tSXPY-4kgpOc9mT_6Hup-RWgdsLGyTlLtlZX3fxGRzX1u55vzN_A3QqPAo priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkxAviG8KAxmExANYaxJ_5QmtaFMHWkGDTRMvluPYWyWUlKaBN_527hK3LELwVtXXOvF9-O58_h0hLwWHOMJljmVScMbtJLAiFSXD9iE65BbEChP6x3M5O-Xvz8V5TLg1saxyYxM7Q13WDnPke4h7lmcavOW3y-8Mu0bh6WpsoXGd7KRJpvWI7EwP5p9OtucIsP_lm6syWu41YI1VzjBkQuwpweRgO-pQ-_-2zVc2p2Hh5JWd6PA2uRVdSLrf8_wOuearu-TGcTwkv0d-Ye0GxRx61y-U2qqkS0yLNZ1_TOtALz0WUq8XDZ3SH4tV29BNUVYFn-hie0uroWAR_QKzDnR2dEaxUAwpPvy0X9tvLZtj9ucN7Rrx0b7n0H1yenjw5d2MxTYLzMksWTNrhS8hKPUQ2oRCuZJL4dNSKO5z5bXNU6cgkPJJmUnJc-51pv2kwMiyDIVw2QMyqurKPyJUJja1ReJ4gCis5GUhfVI4LUJepFboMCavN6ttlj2ahumiEC1NzxsDvDEdb4wckykyZEuJSNjdF_XqwkTFMlYJbyfSOcQVUjBdyUMKk6YhR-fMj8kLZKdBrIsKi2kubNs05ujjmdmXiH-mwGP9F9HnkwHRq0gUauC-s_ECA7w6YmgNKHcHlKCxbji8ES0TLUZj_sj3mDzfDuMvsQqu8nXb02Q5qA_8xcNeEreLk4Et1cCeMVEDGR2s3nCkWlx2eOJKKvDqJo___1hPyM0UFQdLIOUuGa1XrX8KDtm6eBa17jcf3jSk priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGkBAviG8KAxmExAOYNfFX8oDQhpg6UIcEdJp4sRzH3ipN6WgaPl7427lzkrKIwVtVX5PUd2ff73L-HSFPpQAc4bhjXEnBhB0HVqSyZNg-JAu5BbPChP70QE1m4t2RPNogfbujbgLrC6Ed9pOaLU9f_vj68zU4_Kvo8JnarmGN1TlDIISMUpKpS-RyCjsjlnhNxZ-3CrAb5vG0kU5YyrnoD9FceI3BRhX5_P9etc9tW8OSynN71N51cq0LLulOaw03yIavbpIr0-71-S3yC6s6KGbXYydRaquSnmHCrI6RM10EeuKxxHo1r-ku_TZfNjXty7Uq-ETn6_NbNYW10s8xH0En-4cUS8hQ4v13-6U5bdgB5oVe0Niij7bdiG6T2d7bz28mrGvAwJziyYpZK30JcNUD6AmFdqVQ0qel1MLn2mc2T50GiOWTkislcuEznvlxgZizDIV0_A7ZrBaVv0eoSmxqi8SJAPisFGWhfFK4TIa8SK3Mwog872fbnLU8Gybik0yZVjcGdGOibowakV1UyFoSObLjF4vlselczlgtvR0r55BxSMPtShFSuGkacgzb_Ig8QXUaZMGosMzm2DZ1bfY_HJodhcxoGmLZfwl9-jgQetYJhQVo39nuaAP8dWTXGkhuDSTBl91wuDct07uCQca_nGeAE0fk8XoYf4n1cZVfNK0Mz8Gx4BJ3W0tcTw6HVTYD9YyIHtjoYPaGI9X8JDKNa6Uh3hvf__9TPyBXU3QcLI5UW2RztWz8QwjVVsWj6H-_AQXJN_s priority: 102 providerName: Scholars Portal |
| Title | High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33198649 https://www.proquest.com/docview/2461938428 https://search.proquest.com/docview/2461393077 https://pubmed.ncbi.nlm.nih.gov/PMC7670610 https://doaj.org/article/a75ea06cc11547e1bd4f21bc2f96172e |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF61RUJcEO8GSrQgJA7gJn7sw8cmapWCEqpAq6iX1Xq9bi21ThTHcOO3M7O2o1iIC5dVlB3Hzs7MzsOz3xDygUUQR5jQeCFnkRfpYeYlAUs9bB8is1iDWGFCfzrjk8voy4It9ghrz8K4on2T5MfF3f1xkd-62srVvRm0dWKDi-lYcAFmaDjYJ_tgftsQvXl1ACYvbk_HSD4oYQMWsYdREsJNMQ-bFoUgeJIjfuaOMXKY_X_vzDumqVs2uWOHzp6Qx40DSU_qB31K9mzxjDycNq_In5PfWLlBMYPuuoVSXaR0hUmx0nnHdJnRW4tl1Ju8pCP6M19XJW1Lsgr4RPPtGa2Swn5oc8w50Mn5FcUyMaT4-ktfV3eVN8Pcz2fq2vDRuuPQC3J5dvpjPPGaJgue4aG_8bRmNoWQ1EJgkyXCpBFnNkiZiGwsrNRxYASEUdZPQw4rFlkZSjtMMK5Ms4SZ8CU5KJaFPSSU-zrQiW-iDGKwNEoTbv3ESJbFSaCZzHrkU7vaalVjaSgXg0iuajYpYJNybFK8R0bIkC0l4mC7L5brG9VIg9KCWT3kxiCqkIDbpVEWwE2DLEbXzPbIe2SnQqSLAktpbnRVlur825U64Yh-JsBf_RfR93mH6GNDlC2B-0Y3xxfgryOCVofyqEMJ-mq6061oqWa_KBWi-sWhhFiwR95tp_FKrIEr7LKqacIYlAd-4lUtidvFaQW6R0RHRjur150B5XJo4o0yvf7vK9-QRwGqF9ZG8iNysFlX9i14apukD_q5EDDKsd8nD0ans4t532U9YJxGEsb56Lrv9PcPLfBCVw |
| link.rule.ids | 230,314,727,780,784,864,885,2102,12056,12223,21388,24318,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,53791,53793 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegk4AXxDcdAwxC4gGstUlsJ09oRZtathY0tmnixXL8sVWaktI08Mbfzl3ilkUI3qr6Wie-D9-dz78j5A1PII4wsWGx4AlL9MCzPOKWYfuQ1GcaxAoT-tOZGJ8mn875eUi4VaGscm0TG0NtS4M58l3EPcviFLzlD4vvDLtG4elqaKFxk2whcjrvka3R_uzL8eYcAfa_bH1VJhW7FVhjmTEMmRB7ijPR2Y4a1P6_bfO1zalbOHltJzq4R-4GF5LutTy_T2644gG5NQ2H5A_JL6zdoJhDb_qFUl1YusC0WNX4x7T09NJhIfVqXtER_TFf1hVdF2UV8InON7e0KgoW0c0x60DHkzOKhWJIcfhTf6uvajbD7M972jTio23PoUfk9GD_5OOYhTYLzIh4uGJac2chKHUQ2vhcGpsI7iLLZeIy6VKdRUZCIOWGNhYiyRKXxqkb5BhZWp9zEz8mvaIs3FNCxVBHOh-axEMUZhObCzfMTcp9lkeap75P3q1XWy1aNA3VRCGpUC1vFPBGNbxRok9GyJANJSJhN1-UywsVFEtpyZ0eCGMQV0jCdDbxEUwa-QydM9cnr5GdCrEuCiymudB1VanJ5zO1JxD_TILH-i-ir8cdoreByJfAfaPDBQZ4dcTQ6lDudChBY013eC1aKliMSv2R7z55tRnGX2IVXOHKuqWJM1Af-IsnrSRuFicGW5oCe_pEdmS0s3rdkWJ-2eCJSyHBqxts__-xXpLb45PpkTqazA6fkTsRKhGWQ4od0lsta_ccnLNV_iJo4G-wFDeM |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSBMviG8KAwxC4gGytElsJ4_boGoZLROwaeLFcvyxRdrSqmngjb-dOyepGiFeeKvqS5P67uy7y8-_I-QNSyCP0LEOYs6SIFFDF-QRMwG2D0ldpsCssKA_m_PJafLpnJ1vtfryoH2dF_vl1fV-WVx6bOXyWocdTiw8mR0JLmAbGoZL48Kb5BaLwci6RL19gQAbX9adkUl5WMEyLLIAcyUknWIBti6KwfxSjiyaW1uSZ-7_e33e2qD64Mmt3Wh8l9xpw0h60DzuPXLDlvfJ7qx9Uf6A_Eb8BsU6uu8ZSlVp6BJLY5WPkenC0UuLYOp1UdFD-rNY1RXtgFklfKLF5qRWRWFVtAVWHuhkekYRLIYSx7_Uj_qqDuZYAXpPfTM-2vQdekhOxx-_H02CttVCoHk8WgdKMWsgMbWQ3rhcaJNwZiPDRGIzYVOVRVpAMmVHJuYwY4lN49QOc8wujcuZjh-RnXJR2ieE8pGKVD7SiYNMzCQm53aU65S5LI8US92AvOtmWy4bRg3pM5GUy0ZNEtQkvZokH5BDVMhGEtmw_ReL1YVsbUIqwawacq2RW0jA7UziIrhp5DIM0OyAvEZ1SuS7KBFQc6HqqpLTL2fygCMHmoCo9V9C3772hN62Qm4B2teqPcQAfx15tHqSez1J8FrdH-5MS7arRiWR2y-LU8gIB-TVZhivRCRcaRd1IxNn4ELwE48bS9xMTmfQAyJ6Ntqbvf4IuJjnFG9d6ul_X_mS7J58GMvP0_nxM3I7Qk9DsCTfIzvrVW2fQ-i2zl94J_0DEBRAkw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+incidence+and+persistence+of+hepatitis+B+virus+infection+in+individuals+receiving+HIV+care+in+KwaZulu-Natal%2C+South+Africa&rft.jtitle=BMC+infectious+diseases&rft.au=Msomi%2C+Nokukhanya&rft.au=Naidoo%2C+Kogieleum&rft.au=Yende-Zuma%2C+Nonhlanhla&rft.au=Padayatchi%2C+Nesri&rft.date=2020-11-16&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12879-020-05575-6&rft.externalDocID=A642287057 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |